Burzynski Research Institute Inc (BZYR) Gross Profit Margin starting from the third quarter 2025 to third quarter 2024, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket
 


Burzynski Research Institute Inc  (NONE: BZYR)


Burzynski Research Institute Inc's Gross Profit Margin by quarter

Trends, Rankings, Statistics



BZYR Gross Profit Margin (Nov 30 2025)
Q3
(Aug 31 2025)
Q2
(May 31 2025)
Q1
(Feb 28 2025)
Q4
(Nov 30 2024)
Q3
Y / Y Revenue Change -
Seq. Revenue Change -
Revenue In Millions $0.00
Gross Profit Margin -
Gross Profit Margin Total Ranking #
Gross Profit In Millions $0.00
Y / Y Gross Profit Change -
Seq. Gross Profit Change -


Commenting Third Quarter 2025 Gross Profit Margin
Learn about Gross Margin
BZYR's Gross Profit Margin third quarter 2025 Company Ranking
Within: No.
In Vitro & In Vivo Diagnostic Substances Industry #
Healthcare Sector #
Overall # 0

Gross Profit Margin Statistics
High Average Low
0 % 0 % 0 %
 




Other Gross Profit Margin Profitability Ratios
BZYR's Cumulative Gross Profit Margin
In Vitro & In Vivo Diagnostic Substances Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
BZYR's Gross Profit Margin Profitability versus In Vitro & In Vivo Diagnostic Substances Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for BZYR's Competitors
Gross Profit Margin Profit Margin for Burzynski Research Institute Inc's Suppliers
Gross Profit Margin Profit Margin for BZYR's Customers

You may also want to know
BZYR's Annual Growth Rates BZYR's Profitability Ratios BZYR's Asset Turnover Ratio BZYR's Dividend Growth
BZYR's Roe BZYR's Valuation Ratios BZYR's Financial Strength Ratios BZYR's Gross Profit Growth
BZYR's Roa BZYR's Inventory Turnover Ratio BZYR's Growth Rates BZYR's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Nov 30 2025, within In Vitro & In Vivo Diagnostic Substances Industry Gross Profit MarginNov 30 2025 MRQ Gross ProfitNov 30 2025 MRQ Revenue




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.